Microsoft stands out as a good value for 2025 and beyond. The stock isn't overpriced, sporting a 34.9 price-to-earnings (P/E) ...

"Magnificent Seven", a group of mega-cap tech companies that dominates the headlines and plays an outsized role in the ...

Stocks are closing lower as Wall Street ends a holiday-shortened week on a down note. The S&P 500 fell 1.1% Friday and the ...

The chart below shows the clear inverse correlation ... Stocks with sales equivalent to the average Magnificent 7 stock tend to trade with a price to sales ratio below 1. Of course, the ...

an index that tracks the 100 largest non-financial companies on the Nasdaq Stock Exchange. The index fund is heavily invested in the information technology sector, and the Magnificent Seven stocks ...

With Q4 2024 behind investors, some of the uncertainty that served as a potential headwind for the market is now in the ...

Here's why the S&P 500 is on track to rise more than 20% in two consecutive years for the first time since the late 1990s.

Monitor these important chart levels. Dubbed the Magnificent Seven stocks ... current sales numbers aren’t what’s driving the stock.

Investment themes to consider for 2025 include the AI revolution, data centers, power, biotech, regional banks, defense ...

As shown below, the stock lost as much ... The aforementioned 3.7% forward yield is near the best value for AbbVie in 2024, save the November lows seen in the chart above. Income investors should ...